Treatment Use of Oral MKC-1 in a Single Patient: Expansion of MKC-102
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The objective of this study is to provide continued access to oral MKC-1 in a cancer patient who is currently participating in and benefiting from treatment under protocol MKC-102 (IRB # 1010002795).
Description
The objective of this study is to provide continued access to oral MKC-1 in a cancer patient who is currently participating in and benefiting from treatment under protocol MKC-102 (IRB # 1010002795).
Details
| Age | 100years or below |
|---|---|
| Clinical Study Identifier | TX2209 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.